CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Grant or award Director acquired 553 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 536 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Scientific Officer acquired 22,744 shares (option exercise)
- 4 Option exercise Director acquired 1,548 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 5,263 shares at $19.00 ($99,997)
- 4 Open-market buy Director bought 5,030 shares at $19.00 ($95,570)
- 4 Conversion Director acquired 152,446 shares (conversion)
- 4 Conversion Director acquired 489,542 shares (conversion)
- 4 Open-market buy Director bought 1,315 shares at $19.00 ($24,985)
- 4 Conversion Director acquired 4,203,757 shares (conversion)
- 4 Conversion Director acquired 711,447 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 15 · 296 filings